Background Lp(a) is considered a cardiovascular risk factor. Familial hypercholesterolemia (FH, OMIM 143890) is an inherited disorder of lipoprotein metabolism, transmitted in an autosomal dominant manner and clinically characterized by elevated levels of total and low-density lipoprotein … Pharmacological treatment 5. Objectives The aim of this study was to determine the relationship between lipoprotein(a) [Lp(a)] and cardiovascular disease (CVD) in a large cohort of patients with heterozygous familial hypercholesterolemia (FH). Family cascade screening 3. Her low-density lipoprotein (LDL) cholesterol was only in the 150s, but from a family standpoint, it seemed that … LDL cholesterol target attainment 6. Nevertheless, the role of Lp… Non-pharmacological treatment 4. The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol--the so-called "bad" cholesterol--by 50 percent in patients with severe hypercholesterolemia whose … Familial hypercholesterolemia (FH) is a genetic disorder that affects about 1 in 250 people and increases the likelihood of having coronary heart disease at a younger age. FH diagnoses 2. Lipoprotein(a) as a risk factor for calcific aortic valvulopathy in heterozygous familial hypercholesterolemia. Prognosis 1.5 Fraction of FH patients with Lp… I had one patient with what I thought was familial hypercholesterolemia (FH). The role of genetic and environmental factors in determining the variability in plasma lipoprotein(a) [Lp(a)] levels was investigated in 220 members of 14 families with familial hypercholesterolemia (FH) whose plasma Lp… Familial Hypercholesterolemia: 14 standards Monitor and benchmark hospital regions 1. Vuorio A(1), Watts GF(2), Kovanen PT(3). Introduction. Lipoprotein(a) is a low-density lipoprotein variant containing a protein called apolipoprotein(a).Genetic and epidemiological studies have identified lipoprotein(a) as a risk factor for atherosclerosis and related diseases, such as coronary heart disease and stroke.. Lipoprotein… Sibpair studies in families including familial defective apolipoprotein B or familial hypercholesterolemia (FH) heterozygotes have demonstrated that, in addition, mutations in apolipoprotein B and in the LDL receptor (LDL-R) gene may affect Lp… Author information: (1)Mehiläinen … People with FH have increased blood levels of low-density lipoprotein …